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Abstract: Plasmacytoma of the bronchus is a very rare plasma
cell neoplasm affecting the bronchus. Here we report a case of
plasmacytoma of the bronchus treated by radical radiotherapy in
July 2002. The tumor responded very well to treatment and
showed a slow but sustained regression in the size over two years.
Presently, he has completed four and a half years of follow-up
and is free of disease.
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Extramedullary plasmacytoma (EMP) constitutes 3% ofall plasma cell neoplasms.1 It mainly affects the areas
of the upper aerodigestive tract, such as the nasopharynx,
tonsils, paranasal sinuses, nasal cavity, and salivary gland.1
Primary pulmonary plasmacytoma is very rare. More rare
are those arising from the bronchus. Here we present a rare
case of plasmacytoma of the bronchus treated by radical
radiotherapy.
CASE REPORT
A 62-year-old man presented to us in June 2002 with
history of dry cough for the past three months. He also had
three episodes of hemoptysis. He was a nonsmoker. Physical
examination revealed decreased air entry on the left side of
the chest. His complete blood counts, liver and renal func-
tions were within normal limits. ESR was 30 millimeters in 1
hour. Sputum was negative for acid fast bacilli. Chest X-ray
(Figure. 1) showed a large left hilar mass. Bronchoscopy
showed an infiltrative growth involving the left main bron-
chus and left upper lobe bronchus. Contrast enhanced CT
scan (Figure. 2 and Figure. 3) showed a large hyper dense
mass of size 9  7  8 centimeters encasing the left main
bronchus reaching the chest wall. There was no hilar or
mediastinal lymphadenopathy. Bronchoscopic biopsy showed
proliferation of mature plasma cells in an amyloid back-
ground, composed of immunoglobulin light chain deposits
(Figure 4). On special staining with kappa and lambda
antigens, lambda light chain positivity was seen (Figure 4
insert). Serum protein electrophoreses showed a narrow
M-band in the beta-gamma interzone with normal poly-
clonal gamma globulins. M-band was 9.2% (0.05 g/dl).
Immunofixation studies showed the M-band to be com-
posed of lambda light chains only. Urine electrophoresis
was normal. Bone marrow study showed a nomocellular
picture. Quantitative immunoglobulin levels were also
within the normal range (IgG-1230 mg/dl, IgA-255mg/dl,
IgM-261mg/dl) Serum LDH was 368 U/L. Beta-2 micro
globulin was 2739 micrograms/liter (normal range-700 –
3400). C-reactive protein was 0.6 milligrams/deciliter.
There were no bony lesions on skeletal survey. We made
a diagnosis of Extramedullary Plasmacytoma involving
left bronchus.
Patient was treated by Radical external beam radiother-
apy, 50 Gray in 25 fractions over 5 weeks, by anteroposterior/
posteroanterior parallel opposed portals on telecobalt ma-
chine. The target volume included the tumor and regional
nodes with margins. During radiotherapy he had only Grade
1 dyspnea which lasted for one month post radiotherapy and
was managed symptomatically. He tolerated the whole course
of the treatment very well.
The patient was followed up with serial CT scans and
serum protein electrophoresis. CT scans showed a slow but
sustained regression in the size of the tumor over two years.
Partial response was documented in the CT scan done one
and a half month post radiotherapy and complete response
was achieved at 3 years. The CT scan at 3 years (Figure 5)
showed no tumor. Serum M-spike became negative one and
half months posttreatment and remains negative till now.
Presently he has completed four and a half years of follow-up
and is free of disease.
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DISCUSSION
Primary pulmonary plasmacytoma is a very rare neo-
plasm (5% of EMP). Until now only 37 cases has been
reported in the world literature.2 More rare are those arising
from the bronchus per se.3,4 This is the fifth case of plasma-
cytoma of the bronchus to be reported.
Due to its rarity, there are no standard treatment guide-
lines for these cases. Surgical resection has been the mainstay
of treatment in most of the reported cases. Some have tried
local excision followed by radiotherapy. Our case is excep-
tional in that we have used radical radiotherapy treatment
alone. EMP is known for the involvement of regional nodes.
About 30–40% have first echelon nodes at diagnosis or at
relapse. It is generally agreed upon that the regional nodes
should also be addressed while treating EMP. Plasmacytomas
are generally highly responsive to radiotherapy and chemo-
therapy. United Kingdom Myeloma forum recommends a
radiotherapy dose of 40 Gray in 20 fractions for tumors less
than 5 centimeters and up to 50 Gray in 25 fractions for
tumors more than 5 centimeters.5 In our case, the tumor was
large, therefore requiring a dose of 50 Gray in 25 fractions
over 5 weeks to the tumor with first echelon nodes.
In a review of literature on EMP, Etienne et al showed
that complete or partial response following treatment is
achieved in 65%.2 In our case, we have seen a slow but
sustained regression of the tumor. Chao et al treated 16
patients of EMP with radiotherapy and observed that local
control was achieved in 100 % patients.6 The predicted
10-year overall survival rate was 54%. Weber did an exten-
sive literature review on EMP and saw that local control
FIGURE 1. Chest X-ray of the patient before treatment.
FIGURE 2. Pretreatment CT scans of thorax (coronal view).
FIGURE 3. Pretreatment CT scan of thorax (axial section).
FIGURE 4. Histopathological picture H&E stain. (Inset:
Lambda stain).
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ranged from 80%–100% in different studies.5 The 10-year
disease free and overall survival ranged from 50–80%. The
overall 2- and 5-year survivals of pulmonary plasmacytomas
are 66% and 40%, respectively.7
Ozsahin et al. studied 258 patients of solitary plas-
macytoma (bone  206, extramedullary  52).8 Most (n 
214) of the patients received radiotherapy (RT) alone. The
median follow-up was 56 months (range 7–245). The
5-year overall survival, disease-free survival, and local
control rate was 74%, 50%, and 86%, respectively. Pa-
tients with EMP had the best outcomes, especially when
treated with moderate-dose RT.
A significant proportion of cases of EMP do progress to
multiple myeloma during follow up. This occurs after a
median of 1.5– 2.5 years and their clinical course at progres-
sion is similar to those of patients diagnosed with de novo
symptomatic myeloma. In the review of the literature by
Etienne et al., 14% did develop multiple myeloma within 3
years following treatment.2 In the Chao series treated by
radiotherapy, the 5 year rate of conversion to multiple my-
eloma was 31%.6 This mandates close follow up with serial
serum protein electrophoresis even after complete remission
of EMP.
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FIGURE 5. Posttreatment CT scan of thorax (axial section).
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